Skip to main content
. 2002 Mar;46(3):828–833. doi: 10.1128/AAC.46.3.828-833.2002

TABLE 2.

Clinical pharmacokinetic parameters of amphotericin B after a 2-h infusion of liposomal amphotericin B (2 mg/kg) or amphotericin B deoxycholate (0.6 mg/kg)

Parameter (unit)b Result fora:
Pc
Liposomal amphoter-icin B (2 mg/kg) Amphotericin B deoxy-cholate (0.6 mg/kg)
Cmax (μg/ml) 22.9 ± 10 1.43 ± 0.2 <0.01
C24h (μg/ml) 1.9 ± 1.8 0.25 ± 0.03 NS
AUC0-24 (μgh ml−1) 171 ± 126 13.9 ± 2.0 NS
AUC0-∞ (μgh ml−1) 288 ± 209 46.6 ± 7.2 NS
t1/2α (h) 0.56 ± 0.48 0.17 ± 0.14 NS
t1/2β (h) 6.0 ± 2.1 6.8 ± 1.6 NS
t1/2γ (h) 152 ± 116 127 ± 30 NS
V1 (ml/kg) 50.1 ± 19 136 ± 60 <0.05
V (ml/kg) 1,628 ± 876 2,340 ± 202 NS
Vss (ml/kg) 774 ± 550 1,807 ± 239 <0.01
CL (ml h−1 kg−1) 9.7 ± 5.4 13.1 ± 2.0 NS
CLR (ml h−1 kg−1) 0.495 ± 0.25 4.1 ± 0.68 <0.01
CLF (ml h−1 kg−1) 0.488 ± 0.46 5.4 ± 0.91d <0.01
Furine 0.053 ± 0.006 0.32 ± 0.06 <0.01
Ffeces 0.047 ± 0.04 0.43 ± 0.11d <0.01
a

Values are means ± standard deviations (n = 5 subjects per treatment).

b

C24h, concentration of drug in plasma at 24 h.

c

NS, not significant (P > 0.05).

d

n = 4 (incomplete fecal collection in one subject).